UPDATE
: Friday, February 22, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Samsung BioLogics fiasco hardly affects biotech stocks
The suspension of trading of Samsung BioLogics shares did not have a much n...
by Nam Doo-hyun
|
2018-11-16 11:30
라인
Medipost mark profit losses in Q3
Medipost said Thursday that it recorded an operating loss of 780 million wo...
by Lee Han-soo
|
2018-11-15 15:18
라인
[News Focus] Biotechs to suffer shocks from Samsung BioLogics mess
The stock trading suspension of Samsung BioLogics due to the alleged accoun...
by So Jae-hyeon
|
2018-11-15 14:56
라인
Celltrion Healthcare posts ₩212.7 billion in Q3 sales
Celltrion Healthcare, a subsidiary of Celltrion, said Thursday that it reco...
by Lee Han-soo
|
2018-11-15 12:43
라인
Regulators suspend trading of Samsung BioLogics on accounting fraud charges
The Korean Exchange suspended the share trading of Samsung BioLogics on Wed...
by Lee Han-soo
|
2018-11-14 18:28
라인
Alteogen promote antibody-drug conjugate cancer treatment in US
Alteogen said Wednesday that it promoted ALT-P7, an antibody-drug conjugate...
by Lee Han-soo
|
2018-11-14 16:59
라인
GCAM opens new plasma collection centers in US
GCAM, GC’s sister company, said Friday that it has added two additional pla...
by Lee Han-soo
|
2018-11-09 17:58
라인
GC launches Biocon’s antidiabetic biosimilar
GC said Thursday that it has launched Biocon’s Glargia (insulin glargine), ...
by Lee Han-soo
|
2018-11-08 15:46
라인
'Biosimilar makers to benefit from new research accounting guideline'
The Financial Supervisory Service’s recent guidelines for research and deve...
by Nam Doo-hyun
|
2018-11-07 11:23
라인
Biois seeks KOSDAQ listing with ‘technology exception policy’
Biois Corp. said it would utilize the government’s “technology exception po...
by So Jae-hyeon
|
2018-11-06 15:43
라인
Market caps of top 20 drugmakers on KOSPI surged this year
Market capitalizations of high-ranking pharmaceutical and biotech companies...
by Nam Doo-hyun
|
2018-11-06 15:41
라인
Samsung BioLogics to complete Biogen’s call option
Samsung BioLogics posted Tuesday that the transfer of assets related to Sam...
by Lee Han-soo
|
2018-11-06 10:45
라인
Will PharmAbcine be new force on KOSDAQ?
PharmAbcine, an immuno-oncology company, might be a promising biotech firm ...
by Nam Doo-hyun
|
2018-11-05 16:32
라인
Celltrion gets orders for Herzuma in France
Celltrion Healthcare, a subsidiary of Celltrion, said Friday that it has su...
by Lee Han-soo
|
2018-11-02 17:08
라인
Government to help Pharmicell develop therapy for acute kidney injury
Pharmicell said Friday that the Ministry of Health and Welfare has decided ...
by Lee Han-soo
|
2018-11-02 14:16
라인
SLS Bio registers patent for nanotechnology multiplex diagnostic in Europe
SLS Bio said it has registered a patent related to its nanotechnology multi...
by Lee Han-soo
|
2018-11-01 11:03
라인
CrystalGenomics to change molecular targeted therapy from injection to oral drug in trials
CrystalGenomics said it would change the form of an investigational molecul...
by Nam Doo-hyun
|
2018-10-30 10:52
라인
‘I will help make Korea original holder of anticancer drugs’
“Original technologies are important for national development. We will deve...
by So Jae-hyeon
|
2018-10-29 14:43
라인
‘Bio Solution’s value to rise on arthritis cell therapy’
Bio Solution will be able to drive up its market capitalization once it obt...
by Nam Doo-hyun
|
2018-10-25 16:30
라인
Samsung BioLogics posts ₩101.1 billion in Q3 sales
Samsung BioLogics said Wednesday that it recorded 101.1 billion won ($88.7 ...
by Lee Han-soo
|
2018-10-25 11:02
-
1
2
3
4
5
6
7
8
9
10
다음
-
Insurance benefit for breast cancer treatment ‘Faslodex’ put on hold
Celltrion Healthcare posts ₩713.5 billion in 2018 sales
Alteogen applies for P1 trial for Eylea biosimilar
[News Focus] Why did court acquit Ewha hospital staffs in newborns’ death case?
Insurance benefit for breast cancer treatment ‘Faslodex’ put on hold
Celltrion Healthcare posts ₩713.5 billion in 2018 sales
Alteogen applies for P1 trial for Eylea biosimilar
[News Focus] Why did court acquit Ewha hospital staffs in newborns’ death case?
여백
Most viewed
1
‘Hair loss drug Propesia works well for Koreans in long term’
2
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine
3
Government to spend ₩3 trillion on innovative drugs, dementia, medical scientists
4
Ministry OKs Peptron’s P2 clinical trial of Parkinson’s disease treatment
5
State research organ finds new genes expediting gastritis, gastric cancer
6
Hanmi’s RaboneD dominates osteoporosis therapy market
7
Technoclone to supply Handok diagnostic reagent for ADAMTS-13 activity test
8
Severance Hospital transfers colorectal cancer treatment candidate to Israeli firm
9
[News Focus] Will MSD’s new antidiabetic SGLT-2 inhibitor prove effective?
10
Pharma Research Bio wins nod to export botulinum toxin
여백
Opinion
[Reporter’s Notebook] TV dramas misportray mental hospitals
[Column] Patient stabbed doctor to death -- things can’t just go on like this
[Column]Korea’s healthcare industry; do flowers blossom in desert, too?
여백
Back to Top